| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.1 | $0-$5k | 0.00 |
Summary
A vulnerability categorized as problematic has been discovered in DFLabs PTK 1.0.0/1.0.1/1.0.2/1.0.3/1.0.4. This vulnerability affects unknown code. The manipulation results in cross site scripting. This vulnerability is known as CVE-2009-0917. It is possible to launch the attack remotely. No exploit is available.
Details
A vulnerability classified as problematic has been found in DFLabs PTK 1.0.0/1.0.1/1.0.2/1.0.3/1.0.4. Affected is an unknown functionality. The manipulation with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in DFLabs PTK 1.0.0 through 1.0.4 allows remote attackers to inject arbitrary web script or HTML by providing a forensic image containing HTML documents, which are rendered in web browsers during inspection by PTK. NOTE: the vendor states that the product is intended for use in a laboratory with "no contact from / to internet."
The weakness was published 03/16/2009 (Website). The advisory is shared for download at kb.cert.org. This vulnerability is traded as CVE-2009-0917 since 03/16/2009. It is possible to launch the attack remotely. The exploitation doesn't require any form of authentication. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
It is declared as highly functional.
The vulnerability is also documented in the databases at X-Force (49236), SecurityFocus (BID 34111†) and Secunia (SA34257†). Similar entry is available at VDB-47161. VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.1
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Highly functional
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
03/13/2009 🔍03/16/2009 🔍
03/16/2009 🔍
03/16/2009 🔍
03/16/2009 🔍
03/17/2015 🔍
04/23/2025 🔍
Sources
Advisory: kb.cert.orgStatus: Confirmed
CVE: CVE-2009-0917 (🔍)
GCVE (CVE): GCVE-0-2009-0917
GCVE (VulDB): GCVE-100-47160
CERT: 🔍
X-Force: 49236 - PTK unspecified cross-site scripting
SecurityFocus: 34111 - PTK Arbitrary Command Execution and Cross Site Scripting Vulnerabilities
Secunia: 34257 - PTK Cross-Site Scripting and Script Insertion Vulnerabilities, Not Critical
See also: 🔍
Entry
Created: 03/17/2015 23:38Updated: 04/23/2025 14:19
Changes: 03/17/2015 23:38 (48), 11/02/2018 08:21 (9), 11/29/2024 10:52 (17), 04/23/2025 14:19 (2)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.